Paper28293100
Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction.
da Silva JS and 9 others. Drug Des Devel Ther, 2017. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction. Papers, record 28293100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293100
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine A2 Receptor Agonists | Major topic |
| Heart Failure | Major topic |
| Hydrazones | Major topic |
| Myocardial Infarction | Major topic |
| Thiophenes | Major topic |
| Administration, Oral | |
| Animals | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Male | |
| Rats | |
| Rats, Inbred SHR |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AG033727 | NIA NIH HHS | United States | R01AG033727 | PubMed and NIH |
Source NIH RePORTER
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11602667 | A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle. | J Pharmacol Exp Ther | 2001 | https://conductscience.org/library/papers/11602667 | PubMed |
| 2 | 9694911 | Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. | J Pharmacol Exp Ther | 1998 | https://conductscience.org/library/papers/9694911 | PubMed |
| 3 | 11751719 | Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction. | Hypertension | 2001 | https://conductscience.org/library/papers/11751719 | PubMed |
| 4 | 23843027 | Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction. | Heart Vessels | 2014 | https://conductscience.org/library/papers/23843027 | PubMed |
| 5 | 20671720 | LASSBio-294, A compound with inotropic and lusitropic activity, decreases cardiac remodeling and improves Ca²(+) influx into sarcoplasmic reticulum after myocardial infarction. | Am J Hypertens | 2010 | https://conductscience.org/library/papers/20671720 | PubMed |
| 6 | 21094127 | Adenosine and its receptors in the heart: regulation, retaliation and adaptation. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21094127 | PubMed |
| 7 | 20228181 | Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. | Am J Physiol Lung Cell Mol Physiol | 2010 | https://conductscience.org/library/papers/20228181 | PubMed |
| 8 | 17910744 | Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. | Cardiovasc Ultrasound | 2007 | https://conductscience.org/library/papers/17910744 | PubMed |
| 9 | 24269214 | N-acylhydrazone improves exercise intolerance in rats submitted to myocardial infarction by the recovery of calcium homeostasis in skeletal muscle. | Life Sci | 2014 | https://conductscience.org/library/papers/24269214 | PubMed |
| 10 | 19502555 | Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist. | Am J Physiol Heart Circ Physiol | 2009 | https://conductscience.org/library/papers/19502555 | PubMed |
| 11 | 21701502 | Novel therapeutic targets for the treatment of heart failure. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21701502 | PubMed |
| 12 | 495731 | Cardiac function and morphology with aging in the spontaneously hypertensive rat. | Am J Physiol | 1979 | https://conductscience.org/library/papers/495731 | PubMed |
| 13 | 22081230 | Partial adenosine A1 receptor agonists for cardiovascular therapies. | Purinergic Signal | 2012 | https://conductscience.org/library/papers/22081230 | PubMed |
| 14 | 18694365 | Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation. | Expert Opin Investig Drugs | 2008 | https://conductscience.org/library/papers/18694365 | PubMed |
| 15 | 17360992 | The failing heart--an engine out of fuel. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17360992 | PubMed |
| 16 | 20221857 | The emerging role of the selective A2A agonist in pharmacologic stress testing. | J Nucl Cardiol | 2010 | https://conductscience.org/library/papers/20221857 | PubMed |
| 17 | 2844154 | Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization. | Biochem J | 1988 | https://conductscience.org/library/papers/2844154 | PubMed |
| 18 | 16376782 | Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. | J Am Soc Echocardiogr | 2005 | https://conductscience.org/library/papers/16376782 | PubMed |
| 19 | 131652 | Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. | Circ Res | 1976 | https://conductscience.org/library/papers/131652 | PubMed |
| 20 | 24881994 | Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. | Lancet | 2014 | https://conductscience.org/library/papers/24881994 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40801651 | Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease? | Cells | 2025 | https://conductscience.org/library/papers/40801651 | PubMed |
| 40678723 | Adenosine and adenosine receptors: a "double-edged sword" in cardiovascular system. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40678723 | PubMed |
| 40141094 | The Organogermanium Compound 3-(trihydroxygermyl)propanoic Acid Exerts Anti-Inflammatory Effects via Adenosine-NR4A2 Signaling. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141094 | PubMed |
| 39568783 | Novel Agonists of Adenosine Receptors in Animal Model of Acute Myocardial Infarction. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39568783 | PubMed |
| 38721091 | Adipose Tissue Dynamics, Thermogenesis, and Interorgan Connections for Preventing Obesity and Metabolic Disorders. | JMA J | 2024 | https://conductscience.org/library/papers/38721091 | PubMed |
| 38597541 | Antihypertensive Effect of New Agonist of Adenosine Receptor in Spontaneously Hypertensive Rats. | Arq Bras Cardiol | 2024 | https://conductscience.org/library/papers/38597541 | PubMed |
| 38303528 | N-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38303528 | PubMed |
| 38252682 | Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. | Am J Physiol Gastrointest Liver Physiol | 2024 | https://conductscience.org/library/papers/38252682 | PubMed |
| 38139379 | Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139379 | PubMed |
| 38057890 | The effect of extracorporeal shock wave on joint capsule fibrosis based on A2AR-Nrf2/HO-1 pathway in a rat extending knee immobilization model. | J Orthop Surg Res | 2023 | https://conductscience.org/library/papers/38057890 | PubMed |
| 37450948 | Adenosine signaling as target in cardiovascular pharmacology. | Curr Opin Pharmacol | 2023 | https://conductscience.org/library/papers/37450948 | PubMed |
| 36114195 | The evolving view of thermogenic fat and its implications in cancer and metabolic diseases. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36114195 | PubMed |
| 35162950 | Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35162950 | PubMed |
| 34885946 | Effect of S-Se Bioisosteric Exchange on Affinity and Intrinsic Efficacy of Novel N-acylhydrazone Derivatives at the Adenosine A2A Receptor. | Molecules | 2021 | https://conductscience.org/library/papers/34885946 | PubMed |
| 34625737 | The evolving view of thermogenic adipocytes - ontogeny, niche and function. | Nat Rev Endocrinol | 2021 | https://conductscience.org/library/papers/34625737 | PubMed |
| 34437480 | Cardiorespiratory Effects of Three Infusion Doses of Adenosine in Conscious Goats: A Preliminary Study. | Vet Sci | 2021 | https://conductscience.org/library/papers/34437480 | PubMed |
| 33670488 | Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways. | Biomedicines | 2021 | https://conductscience.org/library/papers/33670488 | PubMed |
| 33574762 | Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33574762 | PubMed |
| 33401004 | Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A2A and A2B: potential for therapeutics. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33401004 | PubMed |
| 32727116 | Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32727116 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28293100
GET https://conductscience.org/api/papers/v1/28293100/references?page=2